Perigon Wealth Management, LLC Eli Lilly & CO Transaction History

Perigon Wealth Management, LLC

  • $3.67 Billion
  • Q3 2024

A detailed history of Perigon Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Perigon Wealth Management, LLC holds 38,548 shares of LLY stock, worth $30 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares
38,548
Previous 39,222 1.72%
Holding current value
$30 Million
Previous $35.5 Million 3.83%
% of portfolio
0.93%
Previous 1.04%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024
SELL
$772.14 - $960.02 $520,422 - $647,053
-674 Reduced 1.72%
38,548 $34.2 Million
Q2 2024

Aug 02, 2024
BUY
$724.87 - $909.04 $185,566 - $232,714
256 Added 0.66%
39,222 $35.5 Million
Q1 2024

Apr 29, 2024
SELL
$592.2 - $792.28 $1.2 Million - $1.61 Million
-2,028 Reduced 4.95%
38,966 $30.3 Million
Q4 2023

Jan 29, 2024
BUY
$525.19 - $619.13 $847,656 - $999,275
1,614 Added 4.1%
40,994 $23.9 Million
Q3 2023

Oct 30, 2023
BUY
$434.7 - $599.3 $158,665 - $218,744
365 Added 0.94%
39,380 $21.2 Million
Q2 2023

Aug 02, 2023
BUY
$350.74 - $468.98 $9.08 Million - $12.1 Million
25,875 Added 196.92%
39,015 $18.3 Million
Q1 2023

May 03, 2023
BUY
$310.63 - $364.82 $310,940 - $365,184
1,001 Added 8.25%
13,140 $4.51 Million
Q4 2022

Feb 14, 2023
BUY
$321.55 - $374.67 $379,107 - $441,735
1,179 Added 10.76%
12,139 $4.44 Million
Q3 2022

Dec 13, 2022
SELL
$296.48 - $337.87 $5,929 - $6,757
-20 Reduced 0.18%
10,960 $3.54 Million
Q2 2022

Aug 11, 2022
BUY
$278.73 - $327.27 $508,960 - $597,595
1,826 Added 19.95%
10,980 $3.56 Million
Q1 2022

May 16, 2022
BUY
$234.69 - $291.66 $136,824 - $170,037
583 Added 6.8%
9,154 $2.62 Million
Q4 2021

Feb 11, 2022
BUY
$224.85 - $279.04 $196,968 - $244,439
876 Added 11.38%
8,571 $2.37 Million
Q3 2021

Nov 01, 2021
BUY
$221.6 - $272.71 $1.71 Million - $2.1 Million
7,695 New
7,695 $1.78 Million
Q3 2021

Oct 25, 2021
SELL
$221.6 - $272.71 $1.77 Million - $2.18 Million
-7,978 Closed
0 $0
Q2 2021

Jul 19, 2021
SELL
$180.55 - $233.54 $47,665 - $61,654
-264 Reduced 3.2%
7,978 $1.83 Million
Q1 2021

May 17, 2021
BUY
$164.32 - $212.72 $134,085 - $173,579
816 Added 10.99%
8,242 $1.54 Million
Q4 2020

Jan 28, 2021
BUY
$130.46 - $172.63 $51,401 - $68,016
394 Added 5.6%
7,426 $1.25 Million
Q3 2020

Nov 03, 2020
BUY
$146.22 - $169.13 $200,467 - $231,877
1,371 Added 24.22%
7,032 $1.04 Million
Q2 2020

Jul 29, 2020
BUY
$136.42 - $164.18 $126,324 - $152,030
926 Added 19.56%
5,661 $929,000
Q1 2020

Apr 17, 2020
BUY
$119.05 - $147.35 $249,885 - $309,287
2,099 Added 79.63%
4,735 $690,000
Q4 2019

Jan 13, 2020
BUY
$106.92 - $132.43 $19,031 - $23,572
178 Added 7.24%
2,636 $349,000
Q3 2019

Oct 25, 2019
SELL
$106.79 - $116.16 $64,501 - $70,160
-604 Reduced 19.73%
2,458 $270,000
Q2 2019

Aug 05, 2019
SELL
$110.79 - $129.32 $335,139 - $391,193
-3,025 Reduced 49.7%
3,062 $339,000
Q1 2019

May 15, 2019
SELL
$111.31 - $131.02 $74,021 - $87,128
-665 Reduced 9.85%
6,087 $720,000
Q4 2018

Feb 11, 2019
BUY
$105.9 - $118.64 $494,023 - $553,455
4,665 Added 223.53%
6,752 $776,000
Q3 2018

Nov 13, 2018
BUY
$85.86 - $107.31 $179,189 - $223,955
2,087 New
2,087 $224,000
Q2 2018

Aug 07, 2018
SELL
$75.7 - $86.88 $173,125 - $198,694
-2,287 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$74.21 - $87.6 $5,565 - $6,570
-75 Reduced 3.18%
2,287 $177,000
Q4 2017

Feb 14, 2018
SELL
$81.94 - $87.89 $327 - $351
-4 Reduced 0.17%
2,362 $199,000
Q3 2017

Dec 05, 2017
SELL
$77.07 - $85.54 $2.38 Million - $2.64 Million
-30,917 Reduced 92.89%
2,366 $202,000
Q2 2017

Sep 12, 2017
BUY
N/A
33,283 New
33,283 $2.74 Million
Q3 2011

Nov 14, 2022
SELL
N/A
-20
10,960 $3.54 Million

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
752M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Perigon Wealth Management, LLC Portfolio

Follow Perigon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perigon Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email